MALLINCKRODT FDA Approval NDA 013319

NDA 013319

MALLINCKRODT

FDA Drug Application

Application #013319

Application Sponsors

NDA 013319MALLINCKRODT

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION80%0ANGIO-CONRAYIOTHALAMATE SODIUM

FDA Submissions

TYPE 2; Type 2 - New Active IngredientORIG1AP1996-04-26STANDARD
LABELING; LabelingSUPPL19AP1996-04-26
LABELING; LabelingSUPPL21AP1976-05-06
LABELING; LabelingSUPPL22AP1996-04-26
LABELING; LabelingSUPPL24AP1996-04-26
LABELING; LabelingSUPPL25AP1996-04-26
LABELING; LabelingSUPPL27AP1982-10-19
LABELING; LabelingSUPPL30AP1985-04-16
LABELING; LabelingSUPPL33AP1989-06-28

CDER Filings

MALLINCKRODT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 13319
            [companyName] => MALLINCKRODT
            [docInserts] => ["",""]
            [products] => [{"drugName":"ANGIO-CONRAY","activeIngredients":"IOTHALAMATE SODIUM","strength":"80%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ANGIO-CONRAY","submission":"IOTHALAMATE SODIUM","actionType":"80%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.